• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA TTN 反义 RNA 1 通过调控 miR-139-5p/SPOCK1 轴促进肝癌进展。

Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis.

机构信息

Department of Internal Medicine of Chinese Medicine, Henan University of Chinese Medicine , Zhengzhou, Henan, China.

The First Affiliated Hospital of Henan University of Chinese Medicine , Zhengzhou, Henan, China.

出版信息

Bioengineered. 2021 Dec;12(1):578-588. doi: 10.1080/21655979.2021.1882133.

DOI:10.1080/21655979.2021.1882133
PMID:33517826
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8291788/
Abstract

Reportedly, long non-coding RNAs (lncRNAs) are implicated in hepatocellular carcinoma (HCC) progression, yet little is known concerning the biological functions of TTN antisense RNA 1 (TTN-AS1) in HCC. In this study, quantitative real-time polymerase chain reaction (qRT-PCR) was performed for detecting TTN-AS1, SPOCK1 mRNA, and miR-139-5p expressions in HCC cells and tissues. After TTN-AS1 was overexpressed or knocked down in HCC cells, CCK-8 and 5-Ethynyl-2'-deoxyuridine (EdU) assays were carried out for examining cell multiplication. Transwell assays were conducted for evaluating HCC cell migration and invasion. Dual-luciferase reporter assay was employed for verifying the binding relationships between miR-139-5p and TTN-AS1, and between SPOCK1 3'UTR and miR-139-5p. Western blot was employed to measure SPOCK1, E-cadherin, N-cadherin, and Vimentin protein expressions. We demonstrated that, TTN-AS1 and SPOCK1 expression levels were remarkably enhanced in HCC cells and tissues, whereas miR-139-5p expression was observably reduced. Functional experiments suggested that TTN-AS1 knockdown markedly repressed HCC cell multiplication, migration, epithelial-mesenchymal transition (EMT), and invasion. In addition, TTN-AS1 interacted with miR-139-5p and decreased its expression. Moreover, SPOCK1 was a miR-139-5p target, and miR-139-5p inhibitors were able to reverse TTN-AS1 knockdown-induced inhibitory effect on SPOCK1 expression. SPOCK1 overexpression plasmid could counteract TTN-AS1 knockdown-induced inhibiting impact on HCC cell multiplication, migration, invasion, and EMT. In conclusion, TTN-AS1 expression level is remarkably enhanced in HCC, and TTN-AS1 can promote the multiplication, migration, invasion, and EMT of HCC cells via regulating miR-139-5p/SPOCK1 axis.

摘要

据报道,长链非编码 RNA(lncRNA)参与了肝细胞癌(HCC)的进展,但对于 TTN 反义 RNA 1(TTN-AS1)在 HCC 中的生物学功能知之甚少。在本研究中,通过定量实时聚合酶链反应(qRT-PCR)检测 HCC 细胞和组织中 TTN-AS1、SPOCK1 mRNA 和 miR-139-5p 的表达。在 HCC 细胞中转染 TTN-AS1 过表达或敲低后,通过 CCK-8 和 5-乙炔基-2'-脱氧尿苷(EdU)实验检测细胞增殖。通过 Transwell 实验评估 HCC 细胞迁移和侵袭。双荧光素酶报告实验用于验证 miR-139-5p 与 TTN-AS1 之间以及 SPOCK1 3'UTR 与 miR-139-5p 之间的结合关系。Western blot 用于测量 SPOCK1、E-钙黏蛋白、N-钙黏蛋白和波形蛋白的蛋白表达。结果表明,TTN-AS1 和 SPOCK1 的表达水平在 HCC 细胞和组织中显著升高,而 miR-139-5p 的表达水平显著降低。功能实验表明,TTN-AS1 敲低显著抑制 HCC 细胞增殖、迁移、上皮间质转化(EMT)和侵袭。此外,TTN-AS1 与 miR-139-5p 相互作用并降低其表达。此外,SPOCK1 是 miR-139-5p 的靶基因,miR-139-5p 抑制剂能够逆转 TTN-AS1 敲低诱导的 SPOCK1 表达抑制作用。SPOCK1 过表达质粒可以抵消 TTN-AS1 敲低诱导的对 HCC 细胞增殖、迁移、侵袭和 EMT 的抑制作用。总之,TTN-AS1 在 HCC 中表达水平显著升高,TTN-AS1 可以通过调节 miR-139-5p/SPOCK1 轴促进 HCC 细胞的增殖、迁移、侵袭和 EMT。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d00e/8291788/5761794a586a/KBIE_A_1882133_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d00e/8291788/827ddfa3cb53/KBIE_A_1882133_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d00e/8291788/11a4f83e0dd0/KBIE_A_1882133_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d00e/8291788/dfb4305baa6d/KBIE_A_1882133_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d00e/8291788/fecb4f15223a/KBIE_A_1882133_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d00e/8291788/5761794a586a/KBIE_A_1882133_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d00e/8291788/827ddfa3cb53/KBIE_A_1882133_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d00e/8291788/11a4f83e0dd0/KBIE_A_1882133_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d00e/8291788/dfb4305baa6d/KBIE_A_1882133_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d00e/8291788/fecb4f15223a/KBIE_A_1882133_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d00e/8291788/5761794a586a/KBIE_A_1882133_F0005_OC.jpg

相似文献

1
Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis.长链非编码 RNA TTN 反义 RNA 1 通过调控 miR-139-5p/SPOCK1 轴促进肝癌进展。
Bioengineered. 2021 Dec;12(1):578-588. doi: 10.1080/21655979.2021.1882133.
2
LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.长链非编码 RNA DARS-AS1 通过调控 miR-3200-5p-细胞骨架相关蛋白 2(CKAP2)轴促进肝癌的生长和转移。
Bioengineered. 2021 Dec;12(1):8217-8232. doi: 10.1080/21655979.2021.1982272.
3
Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.长链非编码 RNA AGAP2-AS1 作为竞争性内源性 RNA,通过海绵吸附 miR-16-5p 而上调 ANXA11 的表达,促进肝癌的增殖和转移。
J Exp Clin Cancer Res. 2019 May 14;38(1):194. doi: 10.1186/s13046-019-1188-x.
4
Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.长非编码 RNA MAPKAPK5-AS1/PLAGL2/HIF-1α 信号通路促进肝细胞癌进展。
J Exp Clin Cancer Res. 2021 Feb 17;40(1):72. doi: 10.1186/s13046-021-01868-z.
5
RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.环状 RNA RNF185-AS1 通过靶向 miR-221-5p/整合素 β5 轴促进肝癌进展。
Life Sci. 2021 Feb 15;267:118928. doi: 10.1016/j.lfs.2020.118928. Epub 2020 Dec 31.
6
Long Noncoding RNA TRIM52-AS1 Sponges miR-514a-5p to Facilitate Hepatocellular Carcinoma Progression Through Increasing MRPS18A.长链非编码 RNA TRIM52-AS1 通过海绵吸附 miR-514a-5p 促进肝细胞癌进展
Cancer Biother Radiopharm. 2021 Mar;36(2):211-219. doi: 10.1089/cbr.2019.3271. Epub 2020 May 8.
7
Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.长链非编码 RNA SBF2-AS1 通过调控 miR-140-5p-TGFBR1 通路促进肝癌进展。
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2826-2832. doi: 10.1016/j.bbrc.2018.08.047. Epub 2018 Aug 14.
8
MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating miR-429/ZEB1 axis.MAPKAPK5-AS1 通过调控 miR-429/ZEB1 轴促进肝细胞癌的进展。
BMC Mol Cell Biol. 2022 Apr 25;23(1):21. doi: 10.1186/s12860-022-00420-x.
9
A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.一种新型长链非编码 RNA MCM3AP-AS1 通过靶向 miR-194-5p/FOXA1 轴促进肝癌的生长。
Mol Cancer. 2019 Feb 19;18(1):28. doi: 10.1186/s12943-019-0957-7.
10
LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.长链非编码 RNA MYLK-AS1 通过靶向 miR-424-5p/E2F7 轴和激活血管内皮生长因子受体 2 信号通路促进肝癌的进展和血管生成。
J Exp Clin Cancer Res. 2020 Nov 9;39(1):235. doi: 10.1186/s13046-020-01739-z.

引用本文的文献

1
The Dual Role of ADAMTS9-AS1 in Various Human Cancers: Molecular Pathogenesis and Clinical Implications.ADAMTS9-AS1在多种人类癌症中的双重作用:分子发病机制及临床意义
Anticancer Agents Med Chem. 2025;25(8):533-543. doi: 10.2174/0118715206359325241119075640.
2
SPOCK: Master regulator of malignant tumors (Review).SPOCK:恶性肿瘤的主调控因子(综述)。
Mol Med Rep. 2024 Dec;30(6). doi: 10.3892/mmr.2024.13355. Epub 2024 Oct 11.
3
Identifying pleiotropic genes via the composite test amidst the complexity of polygenic traits.

本文引用的文献

1
LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging miR-16-5p and upregulation of cyclin E1.长链非编码 RNA TTN-AS1 通过海绵吸附 miR-16-5p 和上调细胞周期蛋白 E1 加剧肝癌对索拉非尼的耐药性。
Biomed Pharmacother. 2021 Jan;133:111030. doi: 10.1016/j.biopha.2020.111030. Epub 2020 Nov 28.
2
LncRNAs in the Type I Interferon Antiviral Response.长链非编码 RNA 在 I 型干扰素抗病毒反应中的作用。
Int J Mol Sci. 2020 Sep 3;21(17):6447. doi: 10.3390/ijms21176447.
3
When the Smoke Clears mA from a Y Chromosome-Linked lncRNA, Men Get an Increased Risk of Cancer.
通过复合检验在多基因性状的复杂性中识别多效基因。
Brief Bioinform. 2024 May 23;25(4). doi: 10.1093/bib/bbae327.
4
Disulfidptosis-Associated lncRNAs are Potential Biomarkers for Predicting Immune Response and Prognosis Within Individuals Diagnosed with Hepatocellular Carcinoma.二硫化物诱导细胞焦亡相关长链非编码RNA是预测肝细胞癌患者免疫反应和预后的潜在生物标志物。
Hepat Med. 2023 Dec 27;15:249-264. doi: 10.2147/HMER.S435726. eCollection 2023.
5
The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma.EMT相关非编码RNA调控轴在肝细胞癌中的关键作用。
Front Pharmacol. 2023 Sep 11;14:1270425. doi: 10.3389/fphar.2023.1270425. eCollection 2023.
6
Prognostic significance of long noncoding RNA TTN-AS1 in various malignancies.长链非编码 RNA TTN-AS1 在多种恶性肿瘤中的预后意义。
Cancer Rep (Hoboken). 2023 Oct;6(10):e1876. doi: 10.1002/cnr2.1876. Epub 2023 Aug 2.
7
Making Sense of Antisense lncRNAs in Hepatocellular Carcinoma.解析肝细胞癌中的反义 lncRNA。
Int J Mol Sci. 2023 May 17;24(10):8886. doi: 10.3390/ijms24108886.
8
Significance of exosomes in hepatocellular carcinoma.外泌体在肝细胞癌中的意义。
Front Oncol. 2022 Nov 30;12:1056379. doi: 10.3389/fonc.2022.1056379. eCollection 2022.
9
Chrysophanol exerts a protective effect against sepsis-induced acute myocardial injury through modulating the microRNA-27b-3p/Peroxisomal proliferating-activated receptor gamma axis.大黄素通过调节 microRNA-27b-3p/过氧化物酶体增殖物激活受体γ轴发挥抗脓毒症诱导的急性心肌损伤的保护作用。
Bioengineered. 2022 May;13(5):12673-12690. doi: 10.1080/21655979.2022.2063560.
10
β-Patchoulene represses hypoxia-induced proliferation and epithelial-mesenchymal transition of liver cancer cells.β-石竹烯抑制低氧诱导的肝癌细胞增殖和上皮-间充质转化。
Bioengineered. 2022 May;13(5):11907-11922. doi: 10.1080/21655979.2022.2065945.
当 Y 染色体相关长非编码 RNA 的 mA 消失时,男性患癌症的风险会增加。
Cancer Res. 2020 Jul 1;80(13):2718-2719. doi: 10.1158/0008-5472.CAN-20-0961.
4
SPOCK1 Involvement in Epithelial-to-Mesenchymal Transition: A New Target in Cancer Therapy?SPOCK1参与上皮-间质转化:癌症治疗的新靶点?
Cancer Manag Res. 2020 May 18;12:3561-3569. doi: 10.2147/CMAR.S249754. eCollection 2020.
5
lncRNA TTN-AS1 facilitates proliferation, invasion, and epithelial-mesenchymal transition of breast cancer cells by regulating miR-139-5p/ZEB1 axis.长链非编码RNA TTN-AS1通过调控miR-139-5p/ZEB1轴促进乳腺癌细胞的增殖、侵袭及上皮-间质转化。
J Cell Biochem. 2020 Dec;121(12):4772-4784. doi: 10.1002/jcb.29700. Epub 2020 Feb 26.
6
RETRACTED: Long non-coding RNA TTN-AS1 promotes tumorigenesis of ovarian cancer through modulating the miR-139-5p/ROCK2 axis.撤回:长链非编码 RNA TTN-AS1 通过调节 miR-139-5p/ROCK2 轴促进卵巢癌的发生。
Biomed Pharmacother. 2020 May;125:109882. doi: 10.1016/j.biopha.2020.109882. Epub 2020 Jan 29.
7
LncRNA MALAT1 acts as a miR-125a-3p sponge to regulate FOXM1 expression and promote hepatocellular carcinoma progression.长链非编码RNA MALAT1作为miR-125a-3p的海绵,调节叉头框蛋白M1(FOXM1)的表达并促进肝细胞癌进展。
J Cancer. 2019 Oct 22;10(26):6649-6659. doi: 10.7150/jca.29213. eCollection 2019.
8
LncSNHG3/miR-139-5p/BMI1 axis regulates proliferation, migration, and invasion in hepatocellular carcinoma.长链非编码RNA SNHG3/微小RNA-139-5p/BMI1轴调控肝细胞癌的增殖、迁移和侵袭。
Onco Targets Ther. 2019 Aug 19;12:6623-6638. doi: 10.2147/OTT.S196630. eCollection 2019.
9
LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis.长链非编码RNA TTN-AS1通过miR-134-5p/MBTD1轴调控骨肉瘤细胞凋亡和耐药性。
Aging (Albany NY). 2019 Oct 10;11(19):8374-8385. doi: 10.18632/aging.102325.
10
LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5.长链非编码 RNA TTN-AS1 通过海绵吸附 miR-142-5p 调控 CDK5 促进肺腺癌迁移、侵袭和上皮间质转化。
Cell Death Dis. 2019 Jul 30;10(8):573. doi: 10.1038/s41419-019-1811-y.